IRADIMED CORPORATION (IRMD)
After hours:
| Previous Close | 40.61 |
| Open | 40.99 |
| Bid | 41.73 x 100 |
| Ask | 42.03 x 100 |
| Day's Range | 40.86 - 43.03 |
| 52 Week Range | 36.12 - 51.04 |
| Volume | |
| Avg. Volume | 51,808 |
| Market Cap | 531.056M |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | 31.11 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.15 (0.36%) |
| Ex-Dividend Date | Dec 21, 2023 |
| 1y Target Est | N/A |
- GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
- GlobeNewswire
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at https://www.iradimed.com/investors/events. This ye
- GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.48 for the full year of 2023. Reports fourth quarter of 2023 operating income of $5.2 million, an increase of 21.3%, compared to the same period in 2022 and full-year operating income of $20.0 million, an increase of 28.2%, com
